Publication Name	World Journal of Gastroenterology
Manuscript ID	18858
Country	Russia

Received	2015-04-28 15:36
Peer-Review Started	2015-05-05 21:10
To Make the First Decision	2015-07-13 15:13
Return for Revision	2015-07-17 16:46
Revised	2015-08-14 20:45
Second Decision	2015-09-23 19:47
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-09-30 08:34
Articles in Press	2015-09-30 08:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-09 11:24
Publish the Manuscript Online	2015-11-03 17:31

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Second-line treatment of metastatic gastric cancer: Current options and future directions
Manuscript Source	Invited Manuscript
All Author List	Dheepak Kanagavel, Mikhail Fedyanin, Alexey Tryakin and Sergei Tjulandin
Funding Agency and Grant Number
Corresponding Author	Sergei Tjulandin, Professor, Department of Clinical Pharmacology and Chemotherapy, N. N. Blokhin Russian Cancer Research Center, Kashirskoe Shosse 24, Moscow 115478, Russia. stjulandin@mail.ru
Key Words	Metastatic gastric cancer; Second-line chemotherapy; Targeted therapy; Taxane; Irinotecan; Ramucirumab
Core Tip	This systematic review has analyzed the currently available treatment options with chemotherapy and targeted agents in the second-line treatment of metastatic gastric cancer. In addition, this review has discussed the future directions of research and the prognostic factors that influence patient survival in those receiving second-line therapy for metastatic gastric cancer.
Publish Date	2015-11-03 17:31
Citation	Kanagavel D, Fedyanin M, Tryakin A, Tjulandin S. Second-line treatment of metastatic gastric cancer: Current options and future directions. World J Gastroenterol 2015; 21(41): 11621-11635
URL	http://www.wjgnet.com/1007-9327/full/v21/i41/11621.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i41.11621

Full Article (PDF)	WJG-21-11621.pdf
Full Article (Word)	WJG-21-11621.doc
Manuscript File	18858-Review.docx
Answering Reviewers	18858-Answering reviewers.pdf
Audio Core Tip	18858-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	18858-Conflict-of-interest statement.pdf
Copyright License Agreement	18858-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	18858-Language certificate.pdf
Peer-review Report	18858-Peer-review(s).pdf
Scientific Misconduct Check	18858-Scientific misconduct check.pdf
Scientific Editor Work List	18858-Scientific editor work list.pdf